The Quantikine Human IGFBP-2 Immunoassay is a 3.5 hour solid-phase ELISA designed to measure human IGFBP-2 in cell culture supernates, serum, plasma, and urine. It contains NS0-expressed recombinant human IGFBP-2 and has been shown to accurately quantitate the recombinant factor. Results obtained using natural human IGFBP-2 showed linear curves that were parallel to the standard curves obtai...ned using the Quantikine kit standards. These results indicate that this kit can be used to determine relative mass values for naturally occurring human IGFBP-2.
Store the unopened product at 2 - 8 °C. Do not use past expiration date.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Human IGFBP-2 Quantikine ELISA Kit
BP2
IBP2
IBP-2
IGF-binding protein 2
IGFBP2
IGFBP-2
IGF-BP53
insulin-like growth factor binding protein 2 (36kD)
insulin-like growth factor binding protein 2, 36kDa
insulin-like growth factor-binding protein 2
Background
The superfamily of insulin-like growth factor (IGF) binding proteins include the six high-affinity IGF binding proteins (IGFBP) and at least four additional low-affinity binding proteins referred to as IGFBP related proteins (IGFBP-rP). All IGFBP superfamily members are cysteine-rich proteins with conserved cysteine residues, which are clustered in the amino- and carboxy-terminal thirds of the molecule. IGFBPs modulate the biological activities of IGF proteins. Some IGFBPs may also have intrinsic bioactivity that is independent of their ability to bind IGF proteins. Post-translational modifications of IGFBP, including glycosylation, phosphorylation and proteolysis, have been shown to modify the affinities of the binding proteins to IGF. ALS (Acid Labile Subunit) is a liver-derived protein that exists in a ternary complex with Insulin-like Growth Factor (IGF)-binding Protein-3 (IGFBP-3) or IGFBP-5, and either IGF-I or IGF-II. ALS increases the half-life of IGF/IGFBP complexes in circulation.
⚠ WARNING: This product can expose you to chemicals including N,N-Dimethylforamide, which is known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.
Publications for IGFBP-2 (DGB200)(7)
We have publications tested in 1 confirmed species: Human.